According to Halozyme, the new version of Keytruda infringes on its patents, the report said. USAID cuts put tuberculosis response in peril, WHO says The Trump administration's decision to pause U.S.

WASHINGTON-President Trump put his disruptive return to power on full display during a prime-time address to Congress, offering a no-apologies assessment of his decisions to crack down on illegal ...

In some instances, the pharmaceutical company contributes its own know-how to develop, for example, a target into a compound (e.g., the Bayer ... cope with patent expirations. Wall Street Journal ...

CEO Bill Anderson warned investors that profits will decline in 2025 before the company’s ongoing shake-up leads to an ...

Bayer AG (BAYRY) reports modest sales growth and debt reduction amid financial headwinds and strategic challenges.

Bayer is committed to exactly this. Through its core businesses in agriculture and healthcare, the company focuses on driving sustainable development and generating positive social impact.

Wolfgang will then provide an overview of our financial performance in 2024 along with the outlook for 2025. We will then hear from our Divisional Heads who will delve into last year's performance of ...

Cash call worth about $9 billion based on current value Company says would only use the extra capital if essential Bayer has paid $10 billion on Roundup settlements Share price falls more than 6% ...

Bayer guided for lower earnings this year as it continues to work through a turnaround plan, but said performance is expected ...

Exclusive: Bayer share drop draws market regulator's scrutiny, source says Germany's financial markets watchdog has started an initial probe to examine whether Bayer fairly disclosed plans to get ...